NAFTIN Drug Patent Profile
✉ Email this page to a colleague
When do Naftin patents expire, and what generic alternatives are available?
Naftin is a drug marketed by Sebela Ireland Ltd and is included in three NDAs. There are six patents protecting this drug and one Paragraph IV challenge.
This drug has three patent family members in three countries.
The generic ingredient in NAFTIN is naftifine hydrochloride. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the naftifine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Naftin
A generic version of NAFTIN was approved as naftifine hydrochloride by TARO on January 6th, 2016.
Summary for NAFTIN
International Patents: | 3 |
US Patents: | 6 |
Applicants: | 1 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 87 |
Clinical Trials: | 8 |
Patent Applications: | 738 |
Drug Prices: | Drug price information for NAFTIN |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for NAFTIN |
What excipients (inactive ingredients) are in NAFTIN? | NAFTIN excipients list |
DailyMed Link: | NAFTIN at DailyMed |
Recent Clinical Trials for NAFTIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Therapeutics, Inc. | Phase 1 |
Genzum Life Sciences | Phase 3 |
GenZum Life Sciences LLC | Phase 3 |
Pharmacology for NAFTIN
Drug Class | Allylamine Antifungal |
Anatomical Therapeutic Chemical (ATC) Classes for NAFTIN
Paragraph IV (Patent) Challenges for NAFTIN
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
NAFTIN | Gel | naftifine hydrochloride | 2% | 204286 | 1 | 2015-02-04 |
US Patents and Regulatory Information for NAFTIN
NAFTIN is protected by six US patents.
Patents protecting NAFTIN
Topical compositions and methods for making and using same
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Topical compositions and methods for making and using same
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Topical compositions and methods for making and using same
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Topical compositions and methods for making and using same
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Topical compositions and methods for making and using same
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Topical compositions and methods for making and using same
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF FUNGAL INFECTIONS
Expired US Patents for NAFTIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sebela Ireland Ltd | NAFTIN | naftifine hydrochloride | GEL;TOPICAL | 019356-001 | Jun 18, 1990 | ⤷ Try a Trial | ⤷ Try a Trial |
Sebela Ireland Ltd | NAFTIN | naftifine hydrochloride | CREAM;TOPICAL | 019599-001 | Feb 29, 1988 | ⤷ Try a Trial | ⤷ Try a Trial |
Sebela Ireland Ltd | NAFTIN | naftifine hydrochloride | GEL;TOPICAL | 019356-001 | Jun 18, 1990 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NAFTIN
See the table below for patents covering NAFTIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S6149297 | ⤷ Try a Trial | |
Austria | A293677 | ⤷ Try a Trial | |
Netherlands | 7704401 | ⤷ Try a Trial | |
Finland | 771242 | ⤷ Try a Trial | |
Sweden | 7704478 | ⤷ Try a Trial | |
United Kingdom | 1579879 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |